Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, ...

The NHS in the Black Country is now offering the Respiratory Syncytial Virus (RSV) vaccine at selected local pharmacies, ...

Appointments will continue to be issued over the next couple of weeks and pregnant women who are 28-week-plus are also ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Sanofi is buying Vicebio for more than $1 billion, picking up an experimental vaccine targeting RSV and another respiratory ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about ...

New UK study shows RSV vaccine for pregnant women significantly reduces infant hospital admissions for severe respiratory ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of ...

Winter is here, and with it come higher rates of respiratory illnesses. If you've been struck down recently with a sore ...